Betel quid chewing as an environmental risk factor for breast cancer

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 703, Issue 2, 2010, Pages 143-148

  Kaushal, Mishi ^a   Mishra, Ashwani K ^a   Raju, B S ^a   Ihsan, Rakhshan ^a   Chakraborty, Anurupa ^a   Sharma, Jaganath ^b   Zomawia, Eric ^c   Verma, Yogesh ^d   Kataki, Amal ^b   Kapur, Sujala ^a   Saxena, Sunita ^a  

^a SAFDARJUNG HOSPITAL   (India)

^b A Unit of Tata Memorial Centre   (India)

^c CIVIL HOSPITAL   (India)

^d Sir Thutab Namgyal Memorial Hospital   (India)

Author keywords

Betel quid; Breast cancer; GST; MDR; Polymorphisms

Indexed keywords

CYTOCHROME P450 17; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1; PROTEIN P53;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BETEL NUT; BREAST CANCER; CANCER RISK; CONTROLLED STUDY; DNA POLYMORPHISM; ENVIRONMENTAL EXPOSURE; FEMALE; GENE FREQUENCY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SMOKING HABIT; TOBACCO;

ADULT; ALCOHOL DRINKING; ARECA; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INDIA; MASTICATION; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS; SMOKING; TOBACCO, SMOKELESS;

NICOTIANA TABACUM; PIPER BETEL;

EID: 78549235380     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2010.08.011     Document Type: Article

References (47)

1. Key T.J., Verkasalo P.K., Banks E. Epidemiology of breast cancer. Lancet Oncol. 2001, 2:133-140.
2. Terry P.D., Rohan T.E. Cigarette smoking and the risk of breast cancer in women: a review of the literature. Cancer Epidemiol. Biomarkers Prev. 2002, 11:953-971.
3. Chopra R. The Indian scene. J. Clin. Oncol. 2001, 19:106S-111S.
4. Mudur G. India has some of the highest cancer rates in the world. BMJ 2005, 330:215.
5. Phukan R.K., Ali M.S., Chetia C.K., Mahanta J. Betel nut and tobacco chewing; potential risk factors of cancer of oesophagus in Assam, India. Br. J. Cancer 2001, 85:661-667.
6. Bhattacharjee A., Chakraborty A., Purkaystha P. Prevalence of head and neck cancers in the north east-an institutional study. Indian J. Otolaryngol. Head Neck Surg. 2006, 58(January-March (1)).
7. Phukan R.K., Zomawia E., Narain K., Hazarika N.C., Mahanta J. Tobacco use and stomach cancer in Mizoram, India. Cancer Epidemiol. Biomarkers Prev. 2005, 14:1892-1896.
8. Chaturvedi H.K., Phukan R.K., Mahanta J. The association of selected sociodemographic factors and differences in patterns of substance use: a pilot study in selected areas of Northeast India. Subst. Use Misuse 2003, 38:1305-1322.
9. Gupta P.C., Ray C.S. Epidemiology of betel quid usage. Ann. Acad. Med. Singapore 2004, 33:31-36.
10. Williams J.A., Phillips D.H. Mammary expression of xenobiotic metabolizing enzymes and their potential role in breast cancer. Cancer Res. 2000, 60:4667-4677.
11. Boffetta P., Hecht S., Gray N., Gupta P., Straif K. Smokeless tobacco and cancer. Lancet Oncol. 2008, 9:667-675.
12. Lash T.L., Bradbury B.D., Wilk J.B., Aschengrau A. A case-only analysis of the interaction between N-acetyltransferase 2 haplotypes and tobacco smoke in breast cancer etiology. Breast Cancer Res. 2005, 7:R385-393.
13. Anantharaman D., Chaubal P.M., Kannan S., Bhisey R.A., Mahimkar M.B. Susceptibility to oral cancer by genetic polymorphisms at CYP1A1, GSTM1 and GSTT1 loci among Indians: tobacco exposure as a risk modulator. Carcinogenesis 2007, 28:1455-1462.
14. Pharoah P.D., Dunning A.M., Ponder B.A., Easton D.F. Association studies for finding cancer-susceptibility genetic variants. Nat. Rev. Cancer 2004, 4:850-860.
15. Samson M., Swaminathan R., Rama R., Sridevi V., Nancy K.N., Rajkumar T. Role of GSTM1 (null/present), GSTP1 (Ile105Val) and P53 (Arg72Pro) genetic polymorphisms and the risk of breast cancer: a case control study from South India. Asian Pac. J. Cancer Prev. 2007, 8:253-257.
16. Saxena A., Dhillon V.S., Raish M., Asim M., Rehman S., Shukla N.K., Deo S.V., Ara A., Husain S.A. Detection and relevance of germline genetic polymorphisms in glutathione S-transferases (GSTs) in breast cancer patients from northern Indian population. Breast Cancer Res. Treat. 2009, 115:537-543.
17. Chacko P., Rajan B., Mathew B.S., Joseph T., Pillai M.R. CYP17 and SULT1A1 gene polymorphisms in Indian breast cancer. Breast Cancer 2004, 11:380-388.
18. Tiemersma E.W., Omer R.E., Bunschoten A., van't Veer P., Kok F.J., Idris M.O., Kadaru A.M., Fedail S.S., Kampman E. Role of genetic polymorphism of glutathione-S-transferase T1 and microsomal epoxide hydrolase in aflatoxin-associated hepatocellular carcinoma. Cancer Epidemiol. Biomarkers Prev. 2001, 10:785-791.
19. Zhao M., Lewis R., Gustafson D.R., Wen W.Q., Cerhan J.R., Zheng W. No apparent association of GSTP1 A(313)G polymorphism with breast cancer risk among postmenopausal Iowa women. Cancer Epidemiol. Biomarkers Prev. 2001, 10:1301-1302.
20. Chakraborty A., Murthy N.S., Chintamani C., Bhatnagar D., Mohil R.S., Sharma P.C., Saxena S. CYP17 gene polymorphism and its association with high-risk north Indian breast cancer patients. J. Hum. Genet. 2007, 52:159-165.
21. Liu G., Miller D.P., Zhou W., Thurston S.W., Fan R., Xu L.L., Lynch T.J., Wain J.C., Su L., Christiani D.C. Differential association of the codon 72 p53 and GSTM1 polymorphisms on histological subtype of non-small cell lung carcinoma. Cancer Res. 2001, 61:8718-8722.
22. Cao G., Lu H., Feng J., Shu J., Zheng D., Hou Y. Lung cancer risk associated with Thr495Pro polymorphism of GHR in Chinese population. Jpn. J. Clin. Oncol. 2008, 38:308-316.
23. Vaarala M.H., Mattila H., Ohtonen P., Tammela T.L., Paavonen T.K., Schleutker J. The interaction of CYP3A5 polymorphisms along the androgen metabolism pathway in prostate cancer. Int. J. Cancer 2008, 122:2511-2516.
24. Magnusson C., Wedren S., Rosenberg L.U. Cigarette smoking and breast cancer risk: a population-based study in Sweden. Br. J. Cancer 2007, 97:1287-1290.
25. Alguacil J., Silverman D.T. Smokeless and other noncigarette tobacco use and pancreatic cancer: a case-control study based on direct interviews. Cancer Epidemiol. Biomarkers Prev. 2004, 13:55-58.
26. Boffetta P., Aagnes B., Weiderpass E., Andersen A. Smokeless tobacco use and risk of cancer of the pancreas and other organs. Int. J. Cancer 2005, 114:992-995.
27. Brennan P., Bogillot O., Greiser E., Chang-Claude J., Wahrendorf J., Cordier S., Jockel K.H., Lopez-Abente G., Tzonou A., Vineis P., Donato F., Hours M., Serra C., Bolm-Audorff U., Schill W., Kogevinas M., Boffetta P. The contribution of cigarette smoking to bladder cancer in women (pooled European data). Cancer Causes Control 2001, 12:411-417.
28. Tsai J.F., Chuang L.Y., Jeng J.E., Ho M.S., Hsieh M.Y., Lin Z.Y., Wang L.Y. Betel quid chewing as a risk factor for hepatocellular carcinoma: a case-control study. Br. J. Cancer 2001, 84:709-713.
29. Ko Y.C., Huang Y.L., Lee C.H., Chen M.J., Lin L.M., Tsai C.C. Betel quid chewing, cigarette smoking and alcohol consumption related to oral cancer in Taiwan. J. Oral Pathol. Med. 1995, 24:450-453.
30. Xiong P, Bondy M.L., Li D., Shen H., Wang L.E., Singletary S.E., Spitz M.R., Wei Q. Sensitivity to benzo(a)pyrene diol-epoxide associated with risk of breast cancer in young women and modulation by glutathione S-transferase polymorphisms: a case-control study. Cancer Res. 2001, 61:8465-8469.
31. Nair J., Ohshima H., Friesen M., Croisy A., Bhide S.V., Bartsch H. Tobacco-specific and betel nut-specific N-nitroso compounds: occurrence in saliva and urine of betel quid chewers and formation in vitro by nitrosation of betel quid. Carcinogenesis 1985, 6:295-303.
32. Lee C.H., Lin R.H., Liu S.H., Lin-Shiau S.Y. Mutual interactions among ingredients of betel quid in inducing genotoxicity on Chinese hamster ovary cells. Mutat. Res. 1996, 367:99-104.
33. Rivenson A., Hoffmann D., Prokopczyk B., Amin S., Hecht S.S. Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and Areca-derived N-nitrosamines. Cancer Res. 1988, 48:6912-6917.
34. Sen S., Talukder G., Sharma A. Potentiation of betel-induced alterations of mouse glandular stomach mucosa by tobacco in studies simulating betel addiction. Pharm. Biol. 1987, 25:209-215.
35. van P.J., Bladeren Glutathione conjugation as a bioactivation reaction. Chem. Biol. Interact. 2000, 129:61-76.
36. Karami S., Boffetta P., Rothman N., Hung R.J., Stewart T., Zaridze D., Navritalova M., Mates D., Janout V., Kollarova H., Bencko V., Szeszenia-Dabrowska N., Holcatova I., Mukeria A., Gromiec J., Chanock S.J., Brennan P., Chow W.H., Moore L.E. Renal cell carcinoma, occupational pesticide exposure and modification by glutathione S-transferase polymorphisms. Carcinogenesis 2008, 29:1567-1571.
37. Kim W.J., Kim H., Kim C.H., Lee M.S., Oh B.R., Lee H.M., Katoh T. GSTT1-null genotype is a protective factor against bladder cancer. Urology 2002, 60:913-918.
38. Kushman M.E., Kabler S.L., Ahmad S., Doehmer J., Morrow C.S., Townsend A.J. Protective efficacy of hGSTM1-1 against B[a]P and (+)- or (-)-B[a]P-7,8-dihydrodiol cytotoxicity, mutagenicity, and macromolecular adducts in V79 cells coexpressing hCYP1A1. Toxicol. Sci. 2007, 99:51-57.
39. Landi S. Mammalian class theta GST and differential susceptibility to carcinogens: a review. Mutat. Res. 2000, 463:247-283.
40. Kelsey K.T., Hankinson S.E., Colditz G.A., Springer K., Garcia-Closas M., Spiegelman D., Manson J.E., Garland M., Stampfer M.J., Willett W.C., Speizer F.E., Hunter D.J. Glutathione S-transferase class mu deletion polymorphism and breast cancer: results from prevalent versus incident cases. Cancer Epidemiol. Biomarkers Prev. 1997, 6:511-515.
41. Evans A.J., Henner W.D., Eilers K.M., Montalto M.A., Wersinger E.M., Andersen P.E., Cohen J.I., Everts E.C., McWilliams J.E., Beer T.M. Polymorphisms of GSTT1 and related genes in head and neck cancer risk. Head Neck 2004, 26:63-70.
42. Chaudru V., Lo M.T., Lesueur F., Marian C., Mohamdi H., Laud K., Barrois M., Chompret A., Avril M.F., Demenais F., Bressac-de B., Paillerets Protective effect of copy number polymorphism of glutathione S-transferase T1 gene on melanoma risk in presence of CDKN2A mutations, MC1R variants and host-related phenotypes. Fam. Cancer 2009, 8:371-377.
43. Lemos M.C., Coutinho E., Gomes L., Carrilho F., Rodrigues F., Regateiro F.J., Carvalheiro M. Combined GSTM1 and GSTT1 null genotypes are associated with a lower risk of papillary thyroid cancer. J. Endocrinol. Invest. 2008, 31:542-545.
44. Shimada T., Yamazaki H., Oda Y., Hiratsuka A., Watabe T., Guengerich F.P. Activation and inactivation of carcinogenic dihaloalkanes and other compounds by glutathione S-transferase 5-5 in Salmonella typhimurium tester strain NM5004. Chem. Res. Toxicol. 1996, 9:333-340.
45. Ritchie M.D., Hahn L.W., Roodi N., Bailey L.R., Dupont W.D., Parl F.F., Moore J.H. Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am. J. Hum. Genet. 2001, 69:138-147.
46. Tan S.M., Evans A.J., Lam T.P., Cheung K.L. How relevant is breast cancer screening in the Asia/Pacific region?. Breast 2007, 16:113-119.
47. Wu M.T., Wu D.C., Hsu H.K., Kao E.L., Lee J.M. Constituents of areca chewing related to esophageal cancer risk in Taiwanese men. Dis. Esophagus 2004, 17:257-259.